MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.370
-0.010 (-0.72%)
At close: Dec 5, 2025, 4:00 PM EST
1.420
+0.050 (3.65%)
After-hours: Dec 5, 2025, 5:38 PM EST
MacroGenics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for MacroGenics stock have an average target of 3.20, with a low estimate of 2.00 and a high estimate of 5.00. The average target predicts an increase of 133.58% from the current stock price of 1.37.
Analyst Consensus: Hold
* Price targets were last updated on Nov 3, 2025.
Analyst Ratings
The average analyst rating for MacroGenics stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 7 | 7 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $2 | Hold | Reiterates | $2 | +45.99% | Nov 3, 2025 |
| Barclays | Barclays | Buy Initiates $3 | Buy | Initiates | $3 | +118.98% | Sep 17, 2025 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +118.98% | May 20, 2025 |
| Stifel | Stifel | Hold Maintains $6 → $5 | Hold | Maintains | $6 → $5 | +264.96% | May 14, 2025 |
| Barclays | Barclays | Buy Maintains $8 → $3 | Buy | Maintains | $8 → $3 | +118.98% | May 14, 2025 |
Financial Forecast
Revenue This Year
127.68M
from 149.96M
Decreased by -14.86%
Revenue Next Year
62.88M
from 127.68M
Decreased by -50.75%
EPS This Year
-1.23
from -1.07
EPS Next Year
-1.87
from -1.23
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 152.8M | 122.4M | ||||
| Avg | 127.7M | 62.9M | ||||
| Low | 105.8M | 10.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.9% | -4.1% | ||||
| Avg | -14.9% | -50.7% | ||||
| Low | -29.4% | -91.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.06 | -0.78 | ||||
| Avg | -1.23 | -1.87 | ||||
| Low | -1.47 | -2.65 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.